In the future we plan to make additional investments in product development
and commercialization, which is likely to cause us to remain unprofitable.
Our operating losses and working capital requirements could consume our
current cash balances.
Our net loss for the quarter ended June 30, 2007 was $1,128,751 versus a net
loss for the comparable quarter last year of $787,796. At June 30, 2007, our
cash and short-term investments totaled $11,873,392. If our losses continue,
operations could consume some or all of our cash balances. We expect to make
additional investments in human resources, manufacturing facilities and
equipment, production and application engineering, among other things, in order
to effectively compete in the emerging market for hybrid electric vehicles. We
cannot assure, however, that our existing cash resources will be sufficient to
complete our business plan. Should our existing cash resources be insufficient,
we may need to secure additional funding. We cannot assure you, however, that
funding will be available on terms acceptable to us, if at all.
Some of our contracts can be cancelled with little or no notice and could
restrict our ability to commercialize our technology.
Some of our technology has been developed under government funding by United
States government agencies. In some cases, government agencies in the United
States can require us to obtain or produce components for our systems from
sources located in the United States rather than foreign countries. Our
contracts with government agencies are also subject to the risk of termination
at the convenience of the contracting agency and in some cases grant
"march-in" rights to the government. March-in rights are the right of
the United States government or the applicable government agency, under limited
circumstances, to exercise a non-exclusive, royalty-free, irrevocable worldwide
license to any technology developed under contracts funded by the government to
facilitate commercialization of technology developed with government funding.
March-in rights can be exercised if we fail to commercialize the developed
technology. The implementation of restrictions on our sourcing of components or
the exercise of march-in rights by the government or an agency of the government
could restrict our ability to commercialize our technology.
Some of our orders for the future delivery of products are placed under
blanket purchase orders which are cancelable by our customers at any time prior
to the issuance of non-cancelable product release orders which specify product
delivery dates and quantities to be delivered.
We face intense competition in our motor development and may be unable to
compete successfully.
In developing electric motors for use in vehicles and other applications, we
face competition from very large domestic and international companies, including
the world's largest automobile manufacturers. These companies have far greater
resources to apply to research and development efforts than we have, and they
may independently develop motors that are technologically more advanced than
ours. These competitors also have much greater experience in and resources for
marketing their products.
If we fail to develop and achieve market acceptance for our products, our
business may not grow.
We believe our proprietary systems are suited for a wide range of hybrid
electric vehicle platforms. We currently expect to make substantial investments
in human resources, manufacturing facilities and equipment, production and
application engineering, among other things, to capitalize on the anticipated
expansion in demand for products related to this market area. However, our
experience in this market area is limited. Our sales in this area will depend in
part on the market acceptance of and demand for our proprietary propulsion
systems and future products. We cannot be certain that we will be able to
introduce or market our products, develop other new products or product
enhancements in a timely or cost-effective manner or that our products will
achieve market acceptance.
If we are unable to protect our patents and other proprietary technology, we
will be unable to prevent third parties from using our technology, which would
impair our competitiveness and ability to commercialize our products. In
addition, the cost of enforcing our proprietary rights may be expensive and
result in increased losses.
Our ability to compete effectively against other companies in our industry
will depend, in part, on our ability to protect our proprietary technology.
Although we have attempted to safeguard and maintain our proprietary rights, we
do not know whether we have been or will be successful in doing so. We have
historically pursued patent protection in a limited number of foreign countries
where we believe significant markets for our products exist or where potentially
significant competitors have operations. It is possible that a substantial
market could develop in a country where we have not received patent protection
and under such circumstances our proprietary products would not be afforded
legal protection in these markets. Further, our competitors may independently
develop or patent technologies that are substantially equivalent or superior to
ours. We cannot assure that additional patents will be issued to us or, if they
are issued, as to the scope of their protection. Patents granted may not provide
meaningful protection from competitors. Even if a competitor's products were to
infringe patents owned by us, it would be costly for us to pursue our rights in
an enforcement action, it would divert funds and resources which otherwise could
be used in our operations and we cannot assure that we would be successful in
enforcing our intellectual property rights. In addition, effective patent,
trademark, service mark, copyright and trade secret protection may not be
available in every country where we may operate or sell our products in the
future. If third parties assert technology infringement claims against us, the
defense of the claims could involve significant legal costs and require our
management to divert time and attention from our business operations. If we are
unsuccessful in defending any claims of infringement, we may be forced to obtain
licenses or to pay royalties to continue to use our technology. We may not be
able to obtain any necessary licenses on commercially reasonable terms or at
all. If we fail to obtain necessary licenses or other rights, or if these
licenses are costly, our results of operations may suffer either from reductions
in revenues through our inability to serve customers or from increases in costs
to license third-party technologies.
Use of our motors in vehicles could subject us to product liability claims,
and product liability insurance claims could cause an increase in our insurance
rates or could exceed our insurance limits, which could impair our financial
condition, results of operations and liquidity.
Because some of our motors are designed to be used in vehicles, and because
vehicle accidents can cause injury to persons and property, we are subject to a
risk of claims for product liability. We carry product liability insurance of $1
million covering all of our products. If we were to experience a large insured
loss, it might exceed our coverage limits, or our insurance carriers could
decline to further cover us or raise our insurance rates to unacceptable levels,
any of which could impair our financial position and results of operations.
Forward-Looking Statements
toc
This prospectus and the documents we incorporate by reference contain
statements that constitute "forward-looking statements" within the
meaning of Section 27A of the Securities Act and Section 21E of the Securities
Exchange Act. These statements appear in a number of places in this prospectus
and the documents we incorporate by reference and include statements regarding
our plans, beliefs or current expectations, including those plans, beliefs and
expectations of our officers and directors with respect to, among other things,
revenue growth from sales of Phoenix Motorcars, Inc. improvements in our
financial performance, the development of markets for our products and the
adequacy of our cash balances and liquidity to meet future operating needs.
Important risk factors that could cause actual results to differ from those
contained in the forward-looking statements are listed above under "Risk
Factors."
Use of Proceeds
toc
We will not receive any proceeds from the sale of these shares by the selling
shareholders. The selling shareholders will receive all net proceeds from their
sales of UQM common stock under this prospectus.
Selling Security Holders
toc
In connection with the private issuances of shares of our common stock to the
private placement selling shareholders listed below, we agreed to file a
registration statement with the Securities and Exchange Commission to register
the shares of our common stock we issued to the selling shareholders, and to
keep the registration statement effective until the earliest to occur of:
-
the date when all Shares covered by such
Registration Statement have been sold, or
-
the date on which the Shares may be sold
without any restriction (including the volume limitations) pursuant to
Rule 144(k).
The registration statement of which this prospectus is a part was filed with
the Securities and Exchange Commission pursuant to the securities purchase
agreement we entered into with the selling shareholders on June 26, 2007.
The closing of the private placement occurred on June 26, 2007 and we
issued 1,250,000 shares of our common stock to the private
shareholders.
The following table sets forth, as of July 24, 2007: (1) the
name of each selling shareholder for whom we are registering shares under this
registration statement; (2) the number of shares of our common stock owned
by the selling shareholder prior to this offering; (3) the number of shares
of our common stock being offered pursuant to this prospectus; and (4) the
amount and (if one percent or more) the percentage of the class to be owned by
such selling shareholder after completion of the offering.
This table is prepared based in part on information supplied to us by the
listed selling shareholders. The table assumes that the selling shareholders
sell all of the shares offered under this prospectus. However, because the
selling shareholders may offer from time to time all or some of their shares
under this prospectus, or in another permitted manner, we cannot assure you as
to the actual number of shares that will be sold by the selling shareholders or
that will be held by the selling shareholders after completion of the sales.
Information concerning the selling shareholders may change from time to time and
changed information will be presented in a supplement to this prospectus if and
when necessary and required.
|
|
|
Beneficial
Ownership After
|
|
|
Number
of
|
The
Offering (1)
|
|
Number
of
|
Shares
Being
|
|
|
Private
Placement Selling Shareholders
|
Shares
Owned
|
Offered
|
Number
|
Percent
|
|
|
|
|
|
Heartland
Value Fund
|
1,125,000
|
1,125,000
|
-
|
-
|
|
|
|
|
|
Turn of
the Tide, LP
|
125,000
|
125,000
|
-
|
-
|
|
|
|
|
|
TOTAL
|
1,250,000
|
1,250,000
|
|
|
|
|
|
|
|
(1)Assumes
al
l offered are sold
|
|
|
|
|
Plan of Distribution
toc
This registration statement will permit the shares covered hereby to be
freely tradable if the selling shareholders elect to sell such shares. The
selling shareholders, which as used herein includes their pledgees, donees,
transferees or other successors in interest selling shares of common stock or
interests therein received after the date of this prospectus from a selling
shareholder as a gift, pledge, partnership distribution or other transfer, may
offer the shares from time to time. They may sell the shares sold in one or more
transactions at a fixed offering price, which may be changed, or at varying
prices determined at the time of sale or at negotiated prices. The prices will
be determined by the selling shareholders or by agreement between the selling
shareholders and their agents. The selling shareholders may sell the shares on
the American Stock Exchange or in the over-the-counter market or quotation
service or otherwise, at prices and on terms then prevailing or related to the
then-current market price, or in negotiated transactions. They may sell the
shares using one or more of the following methods or other methods, or in any
combination of such methods:
-
to broker-dealers acting as principals;
-
through broker-dealers acting as agents;
-
in block trades;
-
in agency placements;
-
in exchange distributions;
-
in brokerage transactions;
-
through crosses in which the same broker acts
as an agent on both sides of the trade;
-
in privately negotiated transactions;
-
in transactions other than on exchanges or
services;
-
through the writing of options, whether the
options are listed on an option exchange or otherwise;
-
in connection with the writing of non-traded
and exchange-traded call options or put options, in hedge transactions
and in settlement of other transactions in standardized
over-the-counter options;
-
through the distribution of the shares by any
selling shareholder to its partners, members or shareholders; and
-
by any other method permitted pursuant to
applicable law.
The selling shareholders will act independently of us in making decisions with
respect to the timing, manner and size of each sale or other disposition. To the
extent required, we may amend or supplement this prospectus from time to time to
describe a specific plan of distribution. The selling shareholders or the
purchasers of the shares may pay compensation in the form of discounts,
concessions or commissions to broker-dealers or others who act as agents or
principals or both. The amounts of compensation may be negotiated at the time
and may be in excess of customary commissions. Broker-dealers and any other
persons participating in a distribution of the shares may be underwriters as
that term is defined in the Securities Act, and any discounts, concessions or
commissions may be underwriting discounts or commissions under the Securities
Act. The selling shareholders may grant a security interest in shares owned by
them. If the secured parties foreclose on the shares, they may be selling
shareholders. In addition, the selling shareholders may sell short the shares.
This prospectus may be delivered in connection with short sales and the shares
offered may be used to cover short sales.
Any or all of the sales or other transactions involving the shares described
above, whether completed by the selling shareholders, any broker-dealer or
others, may be made using this prospectus. In addition, any shares that qualify
for sale under Rule 144 of the Securities Act may be sold under
Rule 144 rather than by using this prospectus.
If required under the Securities Act, the number of the shares being offered
and the terms of the offering, the names of any agents, brokers or dealers and
any commission with respect to a particular offer will be set forth in a
prospectus supplement. Certain selling shareholders may have other business
relationships with us and our subsidiaries or affiliates in the ordinary course
of business. Some of the agents and their associates may be customers of, engage
in transactions with or perform services for us in the ordinary course of
business.
The selling shareholders also may enter into hedging transactions with
broker-dealers or other financial institutions and the broker-dealers or other
financial institutions may engage in short sales of the shares in the course of
hedging the positions they assume with the selling shareholders. The selling
shareholders may also enter into option or other transactions or the creation of
one or more derivative securities with broker-dealers or other financial
institutions that involve the delivery of the shares to the broker-dealers or
other financial institutions, who may then resell or otherwise transfer the
shares. The selling shareholders may also pledge the shares to a broker-dealer
or other financial institution and the broker-dealer or other financial
institution may sell or otherwise transfer those shares upon a default. Such
counterparties may receive compensation in the form of discounts, concessions or
commissions from the selling shareholders or the purchasers for whom they act as
agent. In effecting sales, broker-dealers or agents engaged by the selling
shareholders may arrange for other broker-dealers to participate.
Under applicable rules and regulations under the Securities Exchange Act of
1934, as amended, any person engaged in the distribution of the shares may not
simultaneously engage in market making activities with respect to our common
stock for a specified period before the commencement of the distribution. In
addition, the selling shareholders will be subject to applicable provisions of
the Exchange Act and the associated rules and regulations under the Exchange
Act, including Regulation M, which provisions may limit the timing of
purchases and sales of shares of our common stock by the selling shareholders.
We will make copies of this prospectus available to the selling shareholders and
have informed the selling shareholders of the need to deliver copies of this
prospectus to purchasers at or before the time of any sale of the shares.
We will bear all costs, expenses and fees in connection with the registration
of the resale of the shares covered by this prospectus. We have agreed to
indemnify the selling shareholders and their officers, directors, agents,
trustees and affiliates, and each underwriter, if any, for liabilities based on
untrue material facts, or omissions of material facts, contained in this
prospectus and for any failure by us to fulfill any undertakings included in the
registration statement of which this prospectus is a part. The selling
shareholders have agreed to indemnify us for liabilities based on untrue
material facts, or omissions of material facts, contained in this prospectus,
but only to the extent that such material fact or omission is made in reliance
on and in conformity with written information furnished by the selling
shareholders specifically for use in preparation of this prospectus. The selling
shareholders will pay any applicable commissions and expenses, brokerage fees or
transfer taxes. The selling shareholders may agree to indemnify any
broker-dealer or agent that participates in transactions involving sales of the
shares against certain liabilities, including liabilities arising under the
Securities Act.
We cannot assure you that the selling shareholders will sell any or all of
the shares offered by them under this prospectus.
Where You Can Find More Information
toc
We file annual, quarterly and special reports, proxy statements and other
information with the Securities and Exchange Commission ("SEC") under
the Securities Exchange Act of 1934. You may read and copy this information or
obtain copies of this information by mail from the following location at the
SEC:
Public Reference Room
100 F. Street, N.E., Room 1580
Washington, D.C. 20549
You may obtain information on the operation of the Public Reference
Room by calling the SEC at (202) 551-8090. The SEC also maintains an
Internet world wide web site that contains reports, proxy statements and other
information about issuers, like UQM, that file electronically with the SEC. The
address of that site is
http://www.sec.gov
.
We have filed with the SEC a registration statement on Form S-3 that
registers the securities we are offering. The registration statement, including
the attached exhibits and schedules, contains additional relevant information
about us and our securities. The rules and regulations of the SEC allow us to
omit certain information included in the registration statement from this
prospectus.
Incorporation of Certain Documents by Reference
toc
The SEC allows us to "incorporate by reference" information into
this prospectus. This means that we can disclose important information to you by
referring you to another document filed separately with the SEC. The information
incorporated by reference is considered to be part of this prospectus, except
for any information that is superseded by information that is included directly
in this document.
This prospectus incorporates by reference the documents listed below that we
have previously filed with the SEC and that are not included in or delivered
with this document. They contain important information about our company and its
financial condition.